Andrew C. Charles

Dr. Andrew C. Charles excels in the field of neurology, where he serves as a Professor at the University of California, Los Angeles (UCLA). He holds the prestigious Meyer and Renee Luskin Chair in Migraine and Headache Studies. Dr. Charles is renowned for his pioneering research on the mechanisms and functions of astrocyte calcium signaling and glial cell signaling, particularly in the context of central nervous system injury. His research endeavors are primarily centered around understanding the complex pathophysiology of migraine and headache disorders. Dr. Charles has been instrumental in advancing the field through his exploration of the role of calcitonin gene-related peptide (CGRP) in migraine therapy. His work has significantly contributed to the development of new therapeutic approaches for migraine sufferers. Dr. Charles has led numerous clinical trials, providing valuable insights into the effects of chronic caffeine consumption on brain blood flow and its implications for migraine patients. His studies have been pivotal in elucidating the intricate processes that underlie migraine attacks, offering hope for more effective treatments. In addition to his research, Dr. Charles is a prolific author, having published a multitude of articles in esteemed scientific journals. His contributions to the field have been widely recognized, and he is frequently invited to speak at international conferences and symposia. Through his dedication and expertise, Dr. Andrew C. Charles continues to make significant strides in the understanding and treatment of migraine and headache disorders, impacting the lives of countless individuals affected by these conditions. His work not only enhances scientific knowledge but also paves the way for improved patient care and management strategies.